One-liner: Fundación INCLIVA — the foundation that manages the biomedical research of the Hospital Clínico Universitario de Valencia and its Health Department, plus excellence groups from the Universitat de València's Faculty of Medicine and the Fundación Carlos Simón; accredited by Instituto de Salud Carlos III (ISCIII) as an official Instituto de Investigación Sanitaria (IIS), 25 years old in 2026.
What a founder gets
- Clinical-trial networks and translational research access at a major university hospital — a partner to validate a therapy, diagnostic, or medtech device with real patients and clinicians.
- Five structured research areas a startup can align with: cáncer, cardiovascular, salud de la mujer, enfermedades raras, and envejecimiento/inflamación/enfermedades crónicas — useful for targeting the right internal group rather than cold-contacting the institute generically.
- The UPV-CLÍNIC I+D+i health grant program (II edition, open as of the 2026 scrape) — joint UPV–Hospital Clínico funding for health R&D&i projects, a concrete co-funding route for a health-tech/biotech collaboration.
- Intramural calls (convocatorias intramurales) and general ayudas a la investigación — INCLIVA's own internal funding lines, relevant if partnering with an INCLIVA-affiliated researcher.
- Programa IMPULSO de Mentoría Investigadora — a structured 9-month, annual mentoring program (modeled on CSIC's Programa CAMINO and the EURAXESS/FECYT REBECA Mentoring Toolkit) pairing R1 (3rd-year+) researchers with senior R2–R4 mentors. Notably includes a dedicated mentoring track for "Emprendimiento en el ámbito científico-sanitario" (scientific/health entrepreneurship) — led in 2026-2027 by Dr. José Luis García Giménez, founder of EpiDisease S.L. (a CIBER/ISCIII spin-off) — genuine access to a founder-mentor with direct spin-off experience, not just a generic research mentor.
- Scientific-Technological Platforms and researcher support services (Servicios al Personal Investigador, Unidad de Innovación) for co-development.
Who it's for
- Healthtech, medtech, biotech, digital-health, and pharma startups needing clinical validation, real-world evidence, or a hospital co-development/spin-off partner — validation through growth stage.
- The mentoring program's entrepreneurship track is specifically relevant to INCLIVA-affiliated researchers (R1, 3rd year+) considering a spin-off — a narrower but high-value audience than general startup founders.
How to engage
- General collaboration: contact via incliva.es; for national-projects specifically, proyectosnacionales@incliva.es.
- UPV-CLÍNIC grant / intramural calls: check current convocatoria status on the site (Ayudas a la investigación, Convocatorias intramurales sections) — status changes call-to-call,
#status/verifybefore citing a live deadline. - Mentoring program: register as a mentee via the online form; 2026 registration window closed 31 July 2026 (annual program) —
#status/verifynext cycle's opening date. - Address: Fundación INCLIVA, Avd. Menéndez y Pelayo, 4 acc., València · Tel 96 197 35 17.
- Full instrument-level detail on the joint clinical-access route (with FISABIO) is at INCLIVA FISABIO Health Innovation.
Key facts
- 25 years of operation (as of 2026) — "25 años de ciencia mejorando tu salud" is the institute's own framing.
- Accreditation: official Instituto de Investigación Sanitaria (IIS) status from ISCIII (Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades); holds the EU "HR Excellence in Research" (Sello de Excelencia de Recursos Humanos) award from the European Commission.
- Five research areas: Cáncer, Cardiovascular, Salud de la Mujer, Enfermedades Raras, Envejecimiento/Inflamación y Enfermedades Crónicas.
- 2024 institutional metrics (per site, "datos correspondientes a 2024"): counts of research projects awarded, published articles, active clinical trials, patents, and technology-based companies (empresas de base tecnológica) — exact figures not rendered in the captured scrape (dynamic counters);
#status/verifyif precise numbers are needed for a pitch. - Scientific Director: Dr. Andrés Cervantes Ruipérez (per the institutional presentation video).
- Equality recognition: holds the "Fent Empresa. Iguals en Oportunitats" seal from the Generalitat (renewed as of 2026), recognising equality-policy practices.
- Runs its own TERRETA event (2nd edition, rare respiratory/developmental diseases) and an annual women-researcher awards (IV edition in 2026: winners Irene Cánovas, Irene González, Patricia Rodríguez, Clara Bonanad, Iris Garrido).
Relations
- See also: IIS La Fe UCIE
- See also: FISABIO
- See also: Biotech-Health (niche)
- Runs: INCLIVA FISABIO Health Innovation